Research ArticleResearch
Effects of the new prescribing standards in British Columbia on consumption of opioids and benzodiazepines and z drugs
Alexis Crabtree, Caren Rose, Mei Chong and Kate Smolina
Canadian Family Physician May 2019, 65 (5) e231-e237;
Alexis Crabtree
Resident physician in the School of Population and Public Health at the University of British Columbia (UBC) and the British Columbia (BC) Centre for Disease Control in Vancouver.
MD PhDCaren Rose
Assistant Professor in the School of Population and Public Health at UBC and Senior Scientist at the BC Centre for Disease Control.
PhDMei Chong
Biostatistician at the BC Centre for Disease Control.
MScKate Smolina
Adjunct Professor in the School of Population and Public Health at UBC and the Director of the BC Observatory for Population and Public Health at the BC Centre for Disease Control.
PhD
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Canadian Family Physician
Vol. 65, Issue 5
1 May 2019
Effects of the new prescribing standards in British Columbia on consumption of opioids and benzodiazepines and z drugs
Alexis Crabtree, Caren Rose, Mei Chong, Kate Smolina
Canadian Family Physician May 2019, 65 (5) e231-e237;
Jump to section
Related Articles
Cited By...
- Evaluating the intended and unintended consequences of opioid-prescribing interventions on primary care in British Columbia, Canada: protocol for a retrospective population-based cohort study
- Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada